Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jakab, 2014, The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer, Thromb Haemost, 111, 483, 10.1160/TH13-08-0632
Yang, 2016, [Association of preoperative platelet count with the prognosis of patients with colorectal cancer]. [Article in Chinese], Nan Fang Yi Ke Da Xue Xue Bao, 36, 482
Ramirez-Ramirez, 2012, Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer, Arch Med Res, 43, 305, 10.1016/j.arcmed.2012.06.008
Szallasi, 2014, Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma, F1000Res, 3, 180, 10.12688/f1000research.4856.2
Baranyai, 2015, Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor, Pathol Oncol Res, 21, 991, 10.1007/s12253-015-9925-8
Yaylaci, 2005, Prognostic significance of thrombocytosis in node-negative colon cancer, J Int Med Res, 33, 228, 10.1177/147323000503300211
Watanabe, 2013, Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer, Int J Colorectal Dis, 28, 527, 10.1007/s00384-012-1594-4
Watanabe, 2015, Clinical significance of thrombocytosis before preoperative chemoradiotherapy in rectal cancer: predicting pathologic tumor response and oncologic outcome, Ann Surg Oncol, 22, 513, 10.1245/s10434-014-3988-8
Tan, 2015, [Impact of platelet count on prognosis of stage II-III colorectal cancer receiving adjuvant chemotherapy]. [Article in Chinese], Zhonghua Wei Chang Wai Ke Za Zhi, 18, 1261
Bloom, 2014, The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer, Cancer Biomark, 14, 303, 10.3233/CBM-140416
Lee, 2014, Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients, Ann Surg Treat Res, 86, 309, 10.4174/astr.2014.86.6.309
Jensen, 2015, Prognostic factors for overall survival in metastatic colorectal cancer using a stop-and-go FLIRI-based treatment strategy, Int J Colorectal Dis, 30, 1059, 10.1007/s00384-015-2264-0
Zhang, 2014, Baseline neutrophil-lymphocyte ratio (>/=2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation, Radiat Oncol, 9, 295, 10.1186/s13014-014-0295-2
Lee, 2015, Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients, World J Gastroenterol, 21, 12410, 10.3748/wjg.v21.i43.12410
Ren, 2016, Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial, Clin Colorectal Cancer, 10.1016/j.clcc.2016.02.005
McDonald, 2012, Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer, Colorectal Dis, 14, e701, 10.1111/j.1463-1318.2012.03147.x
Cascinu, 2015, Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management, Oncotarget, 6, 33982, 10.18632/oncotarget.5053
Baranyai, 2015, Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer, Int J Surg, 18, 1, 10.1016/j.ijsu.2015.03.005
Kitayama, 2012, Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy, Oncology, 82, 261, 10.1159/000337228
Chang, 2015, The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer, Am J Clin Oncol, 10.1097/COC.0000000000000183
Oh, 2016, Preoperative thrombocytosis predicts prognosis in stage II colorectal cancer patients, Ann Surg Treat Res, 90, 322, 10.4174/astr.2016.90.6.322
Shen, 2012, Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis, Hepatogastroenterology, 59, 1687, 10.5754/hge12277
Abad, 1998, Platelet count and survival in patients with colorectal cancer--a preliminary study, Thromb Haemost, 79, 916, 10.1055/s-0037-1615093
Dennison, 2015, Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases, Med Oncol, 32, 144, 10.1007/s12032-015-0590-2
Kwon, 2014, Clinical implications of systemic inflammatory response markers as independent prognostic factors in colorectal cancer patients, Cancer Res Treat, 46, 65, 10.4143/crt.2014.46.1.65
Xu, 2010, Impact of pretreatment hematologic profile on survival of colorectal cancer patients, Tumour Biol, 31, 255, 10.1007/s13277-010-0024-x
McMillan, 2010, Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer, Colorectal Dis, 12, 987, 10.1111/j.1463-1318.2009.01961.x
Kitayama, 2012, Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer, World J Surg, 36, 192, 10.1007/s00268-011-1329-7
Kusunoki, 2015, Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery, Int Surg, 100, 199, 10.9738/INTSURG-D-13-00178.1
Yang, 2013, Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients, J Gastrointest Cancer, 44, 293, 10.1007/s12029-013-9491-9
Dapunt, 1994, Significance of thrombocytosis in patients with epithelial ovarian cancer, Am J Obstet Gynecol, 170, 549, 10.1016/S0002-9378(94)70225-X
Satomi, 2002, Poor prognosis associated with thrombocytosis in patients with gastric cancer, Ann Surg Oncol, 9, 287, 10.1007/BF02573067
Xia, 2013, Increased platelet count is an indicator of metastasis in patients with nasopharyngeal carcinoma, Tumour Biol, 34, 39, 10.1007/s13277-012-0508-y
Doscherholmen, 1970, Thrombocytosis in patients with lung cancer, JAMA, 211, 1852, 10.1001/jama.1970.03170110058017
Petros, 2000, Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma, BJU Int, 86, 203, 10.1046/j.1464-410x.2000.00792.x
Wu, 2015, Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis, Gut, 64, 1419, 10.1136/gutjnl-2014-308260
Wojtukiewicz, 2004, Platelets and angiogenesis in malignancy, Semin Thromb Hemost, 30, 95, 10.1055/s-2004-822974
Nakahata, 1991, Interleukin-6 supports human megakaryocytic proliferation and differentiation, Blood, 78, 1969, 10.1182/blood.V78.8.1969.1969
Homer-Vanniasinkam, 2007, Platelet function and antiplatelet therapy, Br J Surg, 94, 674, 10.1002/bjs.5852
Barnett, 2009, The acellular fraction of stored platelets promotes tumor cell invasion, J Surg Res, 153, 132, 10.1016/j.jss.2008.04.013
Popel, 2007, Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer, Br J Cancer, 97, 978, 10.1038/sj.bjc.6603923
Sledge, 2002, Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects, Semin Oncol, 29, 104, 10.1053/sonc.2002.34062
Group, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097
Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z
Sydes, 2007, Practical methods for incorporating summary time-to-event data into meta-analysis, Trials, 8, 16, 10.1186/1745-6215-8-16
Laird, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2